Evidence map›Paper›PMID 22685301›Full record

ArticleThe Journal of biological chemistry2012

Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ in brown adipocytes to match fatty acid oxidation with supply.

Emilio P Mottillo, Ainsley E Bloch, Todd Leff, James G Granneman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 193 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Emilio P MottilloCenter for Integrative Metabolic and Endocrine Research, Cardiovascular Research Institute, Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Ainsley E Bloch
Todd Leff
James G Granneman
Wayne State University · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Analysis of Cellular Plasticity in White Adipose Tissue.R01DK062292 · NIDDK · WAYNE STATE UNIVERSITY · PI James G Granneman · 2003 to 2026
$7.6M
Analysis of Lipolytic Trafficking in Adipocytes.R01DK076629 · NIDDK · WAYNE STATE UNIVERSITY · PI James G Granneman, Christopher V Kelly · 2009 to 2026
$7.1M
Analysis of Cellular Plasticity in White Adipose TissueR56DK062292 · NIDDK · WAYNE STATE UNIVERSITY · PI GRANNEMAN, JAMES G · 2005 to 2022
$226k
CIHR MDR-214349NIDDK NIH HHS DK062292NIDDK NIH HHS DK076229NIDDK NIH HHS DK092741NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK062292NIDDK NIH HHS R01 DK076629NIDDK NIH HHS R56 DK062292
6 · The paper itself

Abstract

β-Adrenergic receptors (β-ARs) promote brown adipose tissue (BAT) thermogenesis by mobilizing fatty acids and inducing the expression of oxidative genes. β-AR activation increases the expression of oxidative genes by elevating cAMP, but whether lipolytic products can modulate gene expression is not known. This study examined the role that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) plays in the induction of gene expression. Activation of brown adipocytes by β-AR agonism or 8-bromo-cyclic AMP increased the expression of PGC1α, PDK4, PPARα, uncoupling protein 1 (UCP1), and neuron-derived orphan receptor-1 (NOR-1), and concurrent inhibition of HSL reduced the induction of PGC1α, PDK4, PPARα, and UCP1 but not NOR-1. Similar results were observed in the BAT of mice following pharmacological or genetic inhibition of HSL and in brown adipocytes with stable knockdown of ATGL. Conversely, treatments that increase endogenous fatty acids elevated the expression of oxidative genes. Pharmacological antagonism and siRNA knockdown indicate that PPARα and PPARδ modulate the induction of oxidative genes by β-AR agonism. Using a live cell fluorescent reporter assay of PPAR activation, we demonstrated that ligands for PPARα and -δ, but not PPARγ, were rapidly generated at the lipid droplet surface and could transcriptionally activate PPARα and -δ. Knockdown of ATGL reduced cAMP-mediated induction of genes involved in fatty acid oxidation and oxidative phosphorylation. Consequently, ATGL knockdown reduced maximal oxidation of fatty acids, but not pyruvate, in response to cAMP stimulation. Overall, the results indicate that lipolytic products can activate PPARα and PPARδ in brown adipocytes, thereby expanding the oxidative capacity to match enhanced fatty acid supply.

Indexed as

8-Bromo Cyclic Adenosine MonophosphateAcyltransferasesAdipocytes, BrownAnimalsCells, CulturedFatty AcidsGene Expression RegulationGene Knockdown TechniquesIon ChannelsLipaseLipolysisMiceMice, KnockoutMitochondrial ProteinsOxidation-ReductionPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha8-Bromo Cyclic Adenosine MonophosphateAcyltransferasesFatty AcidsIon ChannelsLipaseMitochondrial ProteinsPdk4 protein, mousePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPNPLA2 protein, mousePPAR alphaPPAR-betaPpargc1a protein, mouseProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseTrans-ActivatorsTranscription FactorsUcp1 protein, mouseUncoupling Protein 1

Identifiers

PMID22685301
PMCPMC3408177
OpenAlexW1981820664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.